SCHEMBL4066370

SCHEMBL4066370

O=C(O)c1cc(-n2ncc(C(F)(F)F)cc2=O)c(Cl)cc1F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SORT1 Q99523 1/20 0.37
MRGPRX4 Q96LA9 1/20 0.36
MAPT P10636 2/20 0.36
POLB P06746 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
GAA P10253 2/20 0.35
MARS1 P56192 1/20 0.35
ATM Q13315 1/20 0.35
KMT2A Q03164 4/20 0.35
MEN1 O00255 3/20 0.35
CRHBP P24387 1/20 0.35
MC4R P32245 1/20 0.35
CRHR2 Q13324 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
GLA P06280 1/20 0.34
HPGD P15428 1/20 0.34
TRPM8 Q7Z2W7 1/20 0.34
PTPN1 P18031 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ASPH Q12797 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4062616 0.90 SORT1 (0.37) SORT1MRGPRX4MAPTPOLBSMN1; SMN2
SCHEMBL31448207 0.90 SORT1 (0.37) SORT1MRGPRX4MAPTPOLBSMN1; SMN2
SCHEMBL5388413 0.79 GAA (0.37) GAAATMKMT2AL3MBTL1GLA
SCHEMBL4679224 0.74 P2RX7 (0.33) MAPTSMN1; SMN2GAAATMKMT2A
SCHEMBL4682095 0.74 PKM (0.34) SMN1; SMN2GAAATMKMT2AMEN1
SCHEMBL7116484 0.74 GAA (0.32) SMN1; SMN2GAAATMKMT2AL3MBTL1
SCHEMBL7018877 0.74 GAA (0.32) SMN1; SMN2GAAATMKMT2AL3MBTL1
SCHEMBL4682067 0.74 SMN1; SMN2 (0.35) SMN1; SMN2GAAATMKMT2AKDM4E
SCHEMBL4680432 0.74 PPARG (0.41) HPGDKDM4E
SCHEMBL6794821 0.73 PPOX (0.44) MAPTGAAATMKMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1226127-B1 SUBSTITUTED PHENYL SULFAMOYL CARBOXAMIDES BASF SE (DE) 2009-07-01 EP disclosed
US-6849618-B2 Uracil substituted phenyl sulfamoly carboxamides BASF AKTIENGESELLSCHAFT (DE) 2005-02-01 US disclosed
US-20040220172-A1 Herbicidal compositions for the desiccation/ defoliation of plants CARLSEN MARIANNE 2004-11-04 US disclosed
CN-1171875-C Uracil substituted phenyl sulfamoyl carboxamides �����ɷ� 2004-10-20 CN disclosed
US-6689773-B2 HERBICIDES BASF AKTIENGESELLSCHAFT (DE) 2004-02-10 US disclosed
US-20030224941-A1 Uracil substituted phenyl sulfamoyl carboxamides CARLSEN MARIANNE (US) 2003-12-04 US disclosed
US-6534492-B2 Herbicidal phenylsulfamoyl carboxamides BASF AKTIENGESELLSCHAFT (DE) 2003-03-18 US disclosed
CN-1383425-A Uracil substituted phenyl sulfamoyl carboxamides BASF AG (DE) 2002-12-04 CN disclosed
EP-1226127-A2 URACIL SUBSTITUTED PHENYL SULFAMOYL CARBOXAMIDES BASF AKTIENGESELLSCHAFT (DE) 2002-07-31 EP disclosed
US-20020045550-A1 Uracil substituted phenyl sulfamoyl carboxamides INTELLECTUAL PROPERTY DEPARTMENT BASF AKTIENGESELLSCHAFT (DE) 2002-04-18 US disclosed
WO-2001083459-A2 URACIL SUBSTITUTED PHENYL SULFAMOYL CARBOXAMIDES BASF AKTIENGESELLSCHAFT (DE) 2001-11-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020045550-A1 Uracil substituted phenyl sulfamoyl carboxamides CCNH, CBR3, UNG SORT1 4699/4885MRGPRX4 3194/4885MAPT 4524/4885
US-20030224941-A1 Uracil substituted phenyl sulfamoyl carboxamides CCNH, CBR3, UNG SORT1 4699/4885MRGPRX4 3194/4885MAPT 4524/4885
US-20040220172-A1 Herbicidal compositions for the desiccation/ defoliation of plants CBR3, HDHD5, DDAH1 SORT1 4761/4885MRGPRX4 2837/4885MAPT 4629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.